Company Search:
Advanced Search
Sponsored Links
Forward Pharma A/S - ADR Company Snapshot
Forward Pharma A/S operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Forward Pharma A/S with three other companies in this sector in the United States: Biomarin Pharmaceutical Inc (2017 sales of $1.31 billion of which 31% was Vimizim), Hypera SA ($1.14 billion ), and Indivior Plc ($1.09 billion of which 100% was Buprenorphine Based Drugs).

Sales Analysis.
  Stock Performance Chart for Forward Pharma A/S - ADR
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): .99
(Figures in U.S. Dollars)
1 Week 7.6%   13 Weeks 0.0%  
4 Weeks 2.1%   52 Weeks -51.9%  
Forward Pharma A/S - ADR Key Data:
  Ticker: FWP Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,249,999,507
(Year Ending Jan 2018).
Employees: 5
  Currency: U.S. Dollars Market Cap: 94,123,125
  Fiscal Yr Ends: December Shares Outstanding: 95,073,864
  Share Type: Common Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.